89 related articles for article (PubMed ID: 30527378)
1. Nation-wide survey of advanced non-melanoma skin cancers treated at dermatology departments in Japan.
Fujisawa Y; Funakoshi T; Nakamura Y; Ishii M; Asai J; Shimauchi T; Fujii K; Fujimoto M; Katoh N; Ihn H
J Dermatol Sci; 2018 Dec; 92(3):230-236. PubMed ID: 30527378
[TBL] [Abstract][Full Text] [Related]
2. Non-Melanoma Skin Cancers: Biological and Clinical Features.
Cives M; Mannavola F; Lospalluti L; Sergi MC; Cazzato G; Filoni E; Cavallo F; Giudice G; Stucci LS; Porta C; Tucci M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751327
[TBL] [Abstract][Full Text] [Related]
3. Incidence and survival rates of primary cutaneous malignancies in Korea, 1999-2019: A nationwide population-based study.
Kwon SH; Choi S; Kim JS; Kim SS; Jue MS; Seo SH; Park J; Roh MR; Mun JH; Kim JY; Choi JW; Byun JW; Park S; Kim MS; Lee SJ;
J Dermatol; 2024 Apr; 51(4):532-538. PubMed ID: 38366757
[TBL] [Abstract][Full Text] [Related]
4. Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).
Ishii M; Hirai I; Tanese K; Fusumae T; Nakamura Y; Fukuda K; Uchi H; Kabashima K; Otsuka A; Yokota K; Yamazaki N; Namikawa K; Fujimura T; Takenouchi T; Yamamoto Y; Nishiguchi M; Sato Y; Amagai M; Funakoshi T
Medicine (Baltimore); 2020 Oct; 99(44):e22913. PubMed ID: 33126349
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibition in Non-Melanoma Skin Cancer: A Review of Current Evidence.
Stonesifer CJ; Djavid AR; Grimes JM; Khaleel AE; Soliman YS; Maisel-Campbell A; Garcia-Saleem TJ; Geskin LJ; Carvajal RD
Front Oncol; 2021; 11():734354. PubMed ID: 34988009
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant Therapy for Non-melanoma Skin Cancer: Updated Therapeutic Approaches for Basal, Squamous, and Merkel Cell Carcinoma.
Zelin E; Zalaudek I; Agozzino M; Dianzani C; Dri A; Di Meo N; Giuffrida R; Marangi GF; Neagu N; Persichetti P; Toffoli L; Conforti C
Curr Treat Options Oncol; 2021 Mar; 22(4):35. PubMed ID: 33725197
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Non-Melanoma Skin Cancers in Salento (Southern Italy): A 15-Year Retrospective Analysis from the Cancer Registry of Lecce.
Sordi E; Piscitelli P; Albanese C; Melcarne A; Tardio A; Quarta F; Greco E; Miani A; Falco A; De Matteis E; Congedo M; Civino A
Epidemiologia (Basel); 2023 Dec; 5(1):1-10. PubMed ID: 38534803
[TBL] [Abstract][Full Text] [Related]
8. Drug therapies in dermatology.
Aslam A; Griffiths CE
Clin Med (Lond); 2014 Feb; 14(1):47-53. PubMed ID: 24532745
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous angiosarcoma: update on biology and latest treatment.
Ishida Y; Otsuka A; Kabashima K
Curr Opin Oncol; 2018 Mar; 30(2):107-112. PubMed ID: 29194075
[TBL] [Abstract][Full Text] [Related]
10. Immune check point inhibitors in advanced cutaneous squamous cell carcinomas: "Repeat and replicate".
Steuer CE; Saba NF
Cancer; 2022 Dec; 128(24):4177-4178. PubMed ID: 36274472
[TBL] [Abstract][Full Text] [Related]
11. Clinical Insights and Dermatological Recommendations for Non-Melanoma Skin Cancers (NMSCs) in Long-Term Hydroxyurea (HU) Therapy.
Iliescu C; Beiu C; Slavu I; Racoviță A; Orlov Slavu C
Cureus; 2024 Mar; 16(3):e57133. PubMed ID: 38681414
[TBL] [Abstract][Full Text] [Related]
12. Patient-Orientated Evaluation of Treatment of Non-Melanoma Skin Cancer with Rhenium-188 Compared to Surgery.
Krönert MIC; Schwarzenböck SM; Kurth J; Heuschkel M; Krause BJ; Emmert S; Tietze JK
Healthcare (Basel); 2024 Apr; 12(9):. PubMed ID: 38727478
[TBL] [Abstract][Full Text] [Related]
13. ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project.
Bosnic-Anticevich S; Costa E; Menditto E; Lourenço O; Novellino E; Bialek S; Briedis V; Buonaiuto R; Chrystyn H; Cvetkovski B; Di Capua S; Kritikos V; Mair A; Orlando V; Paulino E; Salimäki J; Söderlund R; Tan R; Williams DM; Wroczynski P; Agache I; Ansotegui IJ; Anto JM; Bedbrook A; Bachert C; Bewick M; Bindslev-Jensen C; Brozek JL; Canonica GW; Cardona V; Carr W; Casale TB; Chavannes NH; Correia de Sousa J; Cruz AA; Czarlewski W; De Carlo G; Demoly P; Devillier P; Dykewicz MS; Gaga M; El-Gamal Y; Fonseca J; Fokkens WJ; Guzmán MA; Haahtela T; Hellings PW; Illario M; Ivancevich JC; Just J; Kaidashev I; Khaitov M; Khaltaev N; Keil T; Klimek L; Kowalski ML; Kuna P; Kvedariene V; Larenas-Linnemann DE; Laune D; Le LTT; Lodrup Carlsen KC; Mahboub B; Maier D; Malva J; Manning PJ; Morais-Almeida M; Mösges R; Mullol J; Münter L; Murray R; Naclerio R; Namazova-Baranova L; Nekam K; Nyembue TD; Okubo K; O'Hehir RE; Ohta K; Okamoto Y; Onorato GL; Palkonen S; Panzner P; Papadopoulos NG; Park HS; Pawankar R; Pfaar O; Phillips J; Plavec D; Popov TA; Potter PC; Prokopakis EP; Roller-Wirnsberger RE; Rottem M; Ryan D; Samolinski B; Sanchez-Borges M; Schunemann HJ; Sheikh A; Sisul JC; Somekh D; Stellato C; To T; Todo-Bom AM; Tomazic PV; Toppila-Salmi S; Valero A; Valiulis A; Valovirta E; Ventura MT; Wagenmann M; Wallace D; Waserman S; Wickman M; Yiallouros PK; Yorgancioglu A; Yusuf OM; Zar HJ; Zernotti ME; Zhang L; Zidarn M; Zuberbier T; Bousquet J
Allergy; 2019 Jul; 74(7):1219-1236. PubMed ID: 30565275
[TBL] [Abstract][Full Text] [Related]
14. Dermatology today and tomorrow: from symptom control to targeted therapy.
Blume-Peytavi U; Bagot M; Tennstedt D; Saint Aroman M; Stockfleth E; Zlotogorski A; Mengeaud V; Schmitt AM; Paul C; Lim HW; Georgescu V; Dréno B; Nocera T
J Eur Acad Dermatol Venereol; 2019 Jan; 33 Suppl 1():3-36. PubMed ID: 30561009
[TBL] [Abstract][Full Text] [Related]
15. Interstitial Pneumonia in Psoriasis.
Kawamoto H; Hara H; Minagawa S; Numata T; Araya J; Kaneko Y; Umezawa Y; Asahina A; Nakagawa H; Kuwano K
Mayo Clin Proc Innov Qual Outcomes; 2018 Dec; 2(4):370-377. PubMed ID: 30560239
[TBL] [Abstract][Full Text] [Related]
16. Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide.
Rios A; Cen P; Dinh B; Mays SR; Patel AB
Eur J Cancer; 2019 Jan; 107():97-99. PubMed ID: 30554075
[No Abstract] [Full Text] [Related]
17. Clinical characterization of colitis arising from anti-PD-1 based therapy.
Wang DY; Mooradian MJ; Kim D; Shah NJ; Fenton SE; Conry RM; Mehta R; Silk AW; Zhou A; Compton ML; Al-Rohil RN; Lee S; Voorhees AL; Ha L; McKee S; Norrell JT; Mehnert J; Puzanov I; Sosman JA; Chandra S; Gibney GT; Rapisuwon S; Eroglu Z; Sullivan R; Johnson DB
Oncoimmunology; 2019; 8(1):e1524695. PubMed ID: 30546965
[TBL] [Abstract][Full Text] [Related]
18. Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors.
Hasan Ali O; Berner F; Bomze D; Fässler M; Diem S; Cozzio A; Jörger M; Früh M; Driessen C; Lenz TL; Flatz L
Eur J Cancer; 2019 Jan; 107():8-14. PubMed ID: 30529903
[TBL] [Abstract][Full Text] [Related]
19. Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study.
Okada N; Kawazoe H; Takechi K; Matsudate Y; Utsunomiya R; Zamami Y; Goda M; Imanishi M; Chuma M; Hidaka N; Sayama K; Kubo Y; Tanaka A; Ishizawa K
Clin Ther; 2019 Jan; 41(1):59-67. PubMed ID: 30528047
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of skin cancer based on Japan's National Cancer Registry 2016-2017.
Ogata D; Namikawa K; Nakano E; Fujimori M; Uchitomi Y; Higashi T; Yamazaki N; Kawai A
Cancer Sci; 2023 Jul; 114(7):2986-2992. PubMed ID: 37095610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
